There is nothing quite like digging into the miscellaneous bucket of the US market to see the sheer absurdity of 2026. What we have here is a wild mix of forgotten orphans, delisting survivors, and a few hidden giants quietly printing money. Half of these companies are desperately slapping "Agentic AI" into their press releases just to stay relevant, while others are actually building the infrastructure of the future. This is stupid and here's why: you need to separate the real operators from the buzzword bingo players.

Let’s start with the adults in the room. Ecolab (ECL.US) is supposed to be a boring water and hygiene company, but they just closed their acquisition of CoolIT Systems on July 2 to dominate direct liquid cooling for AI data centers. They are targeting a USD 4 billion high-tech business by 2030, and their recent market performance reflects that momentum. Why chase speculative chip stocks when you can just cool the servers down? Similarly, ARM HOLDINGS PLC ADRHEDGED (ARMH.US) continues to ride the massive AI infrastructure spending wave. It is the underlying architecture of the boom, and its stock has easily outpaced the broader hardware sector this year.

Then we have the AI pretenders. Freight Technologies (FRGT.US) has seen its valuation plummet this year. They are busy firing people and scaling back operations, while raising a meager USD 1.2 million on July 15 to pivot to an "AI-native" logistics platform. Good luck with that transition while burning cash. Lucas GC (LGCL.US), a Chinese HR tech play, is playing the exact same game and its stock has been hammered lately. They touted new LLM patents in June, only to abruptly cancel a USD 20 million equity offering in July while their CTO headed for the exits. No amount of AI jargon can mask deteriorating fundamentals.

The struggling micro-caps are equally grim. Nauticus Robotics (KITT.US) has slumped all year, forcing them to execute debt exchanges in late June just to artificially prop up their stockholders' equity. Yet in August, they are tossing AI buzzwords into autonomous robot submarines. Speaking of staying afloat, The GrowHub (TGHL.US) is a blockchain supply chain outfit currently fighting a Nasdaq delisting notice issued on June 5, and their CFO just resigned in late July. It is a classic end-of-the-cycle washout.

Don't think the SPAC era is totally dead—just zombified. SilverBox Corp IV (SBXD.U.US) has been trading sideways in a coma. They were supposed to merge with a Bitcoin asset manager back in August 2025, but on August 4, 2026, they just punted the deadline out to the end of the year. Why aren't you moving faster? Because the market for this is frozen.

In the biotech and consumer aisles, everyone is just trying to survive. Neurocrine Biosciences (NBIX.US) has seen choppy trading recently, prompting a leadership reshuffle on July 23 with three new SVPs to kickstart growth. Clinical-stage Marker Therapeutics (MRKR.US) remains weak, burning through its remaining USD 17 million cash pile on its Phase 1 trials. And Perrigo (PRGO.US)? The consumer health giant is watching its sales shrink—down 3.2% year-over-year to USD 1.02 billion in Q2—and is desperately selling off units for USD 359 million just to pay down debt.

This article does not constitute investment advice.